Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

NCT01212237 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT01212237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01212237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Withdrawn
Start date
May 14, 2012
Completion date
April 13, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors